01—Abstract
Summary
Summary of the 8-K filed December 4, 2025. Cited figures are marked; the original filing is the authoritative source.
On December 4, 2025, Exelon (EXC) closed a $1.0 billiona private offering of 3.25% convertible senior notes due March 15, 2029.
The total includes the full $100 millionb over-allotment option that the initial purchasers exercised, raising the base deal from the $900 million announced on December 1. The company estimates net proceeds of about $987.5 million before other offering expenses, which it intends to use to repay or refinance debt or for general corporate purposes. The notes are senior unsecured obligations, structurally junior to all subsidiary liabilities, and the company cannot redeem them before maturity.
The conversion price is about $57.11c per share (17.5093 shares per $1,000 principal), a roughly 25% premium to the December 1, 2025 closing price, implying a reference price near $45.70. Exelon can settle conversions in cash up to principal, with the excess paid in cash, shares, or a combination at its election. This structure limits share dilution to the in-the-money value above par.
Holders can convert freely only on or after December 15, 2028, and before that only under certain conditions. Holders can also require repurchase at par plus accrued interest upon a fundamental change, and a make-whole share increase may apply in some cases. For investors, the deal is a low-coupon, dilution-managed financing that adds about $1 billiond of liquidity and extends the maturity profile into 2029.
The main considerations are the added leverage in a capital-intensive utility, the cash-settlement flexibility, and the potential future equity issuance if the stock rises above $57.11 and the company elects to settle in shares. The 8-K does not disclose pro forma leverage or a specific debt-reduction schedule, so the net effect on credit metrics would require review of the company's filings and rating agency commentary.
02—Key points
Key Highlights
- Exelon closed $1.0 billion of 3.25% convertible senior notes due March 15, 2029, including the full $100 million over-allotment option.
- Estimated net proceeds are about $987.5 million before other offering expenses, to be used to repay or refinance debt or for general corporate purposes.
- The initial conversion price is about $57.11 per share (17.5093 shares per $1,000), a roughly 25% premium to the December 1, 2025 closing price.
- Exelon can settle conversions with cash up to principal, with the excess paid in cash, stock, or both at its election, which limits dilution.
- Holders may convert freely only on or after December 15, 2028, or earlier under specified conditions; the company cannot redeem the notes before maturity.
- Upon a fundamental change, holders may require repurchase at 100% of principal plus accrued interest, and a make-whole share increase may apply in certain cases.
- The notes were sold under Rule 144A to qualified institutional buyers and are unregistered; the maximum share issuance is 21.8866 shares per $1,000 principal, including any make-whole increase.
03—Questions
Frequently Asked Questions
How much did Exelon raise and what will the money be used for?
Exelon raised $1.0 billion in aggregate principal, which includes the $100 million over-allotment option. Estimated net proceeds are about $987.5 million before other offering expenses. The company intends to use the proceeds to repay or refinance debt or for general corporate purposes.
What is the conversion price and how does it compare to the stock price?
The initial conversion rate is 17.5093 shares per $1,000 principal, equal to a conversion price of about $57.11 per share. That is roughly a 25% premium to Exelon's closing price on December 1, 2025, implying a reference price of about $45.70.
How could the notes dilute existing shareholders?
Exelon must pay cash up to the principal amount of any converted notes, which limits dilution. Only the conversion value above principal could be settled in shares or cash, at Exelon's election. Dilution would occur only if the stock trades above about $57.11 and the company chooses share settlement. The maximum share issuance, including any make-whole increase, is 21.8866 shares per $1,000 principal.
When can holders convert, and can Exelon redeem the notes early?
Holders may convert only under certain conditions before the close of business on December 14, 2028. From December 15, 2028 until the business day before maturity on March 15, 2029, they may convert at any time. Exelon cannot redeem the notes before maturity.
What protections do noteholders have if Exelon undergoes a major change?
If a fundamental change occurs, subject to certain conditions, holders may require Exelon to repurchase their notes for cash at 100% of principal plus accrued and unpaid interest. In some cases involving a make-whole fundamental change, Exelon may also have to increase the conversion rate by a specified number of shares.
04—Continue